170 related articles for article (PubMed ID: 19095153)
1. Melanoma and genetics.
Nelson AA; Tsao H
Clin Dermatol; 2009; 27(1):46-52. PubMed ID: 19095153
[TBL] [Abstract][Full Text] [Related]
2. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
[TBL] [Abstract][Full Text] [Related]
3. Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.
Council ML; Gardner JM; Helms C; Liu Y; Cornelius LA; Bowcock AM
Exp Dermatol; 2009 May; 18(5):485-7. PubMed ID: 19320745
[TBL] [Abstract][Full Text] [Related]
4. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
Pho L; Grossman D; Leachman SA
Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
[TBL] [Abstract][Full Text] [Related]
5. Melanoma genetics: an update on risk-associated genes.
Udayakumar D; Tsao H
Hematol Oncol Clin North Am; 2009 Jun; 23(3):415-29, vii. PubMed ID: 19464594
[TBL] [Abstract][Full Text] [Related]
6. Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.
Fargnoli MC; Altobelli E; Keller G; Chimenti S; Höfler H; Peris K
Melanoma Res; 2006 Apr; 16(2):175-82. PubMed ID: 16567973
[TBL] [Abstract][Full Text] [Related]
7. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations.
Goldstein AM; Landi MT; Tsang S; Fraser MC; Munroe DJ; Tucker MA
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2208-12. PubMed ID: 16172233
[TBL] [Abstract][Full Text] [Related]
8. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
Figl A; Thirumaran RK; Ugurel S; Gast A; Hemminki K; Kumar R; Schadendorf D
Arch Dermatol; 2007 Apr; 143(4):495-9. PubMed ID: 17438182
[TBL] [Abstract][Full Text] [Related]
9. High- and low-penetrance cutaneous melanoma susceptibility genes.
Fargnoli MC; Argenziano G; Zalaudek I; Peris K
Expert Rev Anticancer Ther; 2006 May; 6(5):657-70. PubMed ID: 16759158
[TBL] [Abstract][Full Text] [Related]
10. Genetics of melanoma susceptibility.
Ghiorzo P; Scarrà GB
Forum (Genova); 2003; 13(2):114-22; quiz 187. PubMed ID: 14732879
[TBL] [Abstract][Full Text] [Related]
11. Malignant melanoma--a genetic overview.
Bloethner S; Scherer D; Drechsel M; Hemminki K; Kumar R
Actas Dermosifiliogr; 2009 Nov; 100 Suppl 1():38-51. PubMed ID: 20096196
[TBL] [Abstract][Full Text] [Related]
12. Influence of loss of function MC1R variants in genetic susceptibility of familial melanoma in Spain.
de Torre C; Garcia-Casado Z; Martínez-Escribano JA; Botella-Estrada R; Bañuls J; Oliver V; Mercader P; Azaña JM; Frias J; Nagore E
Melanoma Res; 2010 Aug; 20(4):342-8. PubMed ID: 20539244
[TBL] [Abstract][Full Text] [Related]
13. Genetics in melanoma.
Stahl S; Bar-Meir E; Friedman E; Regev E; Orenstein A; Winkler E
Isr Med Assoc J; 2004 Dec; 6(12):774-7. PubMed ID: 15609895
[TBL] [Abstract][Full Text] [Related]
14. Identification and functional analysis of novel variants of the human melanocortin 1 receptor found in melanoma patients.
Pérez Oliva AB; Fernéndez LP; Detorre C; Herráiz C; Martínez-Escribano JA; Benítez J; Lozano Teruel JA; García-Borrón JC; Jiménez-Cervantes C; Ribas G
Hum Mutat; 2009 May; 30(5):811-22. PubMed ID: 19338054
[TBL] [Abstract][Full Text] [Related]
15. Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.
Eliason MJ; Hansen CB; Hart M; Porter-Gill P; Chen W; Sturm RA; Bowen G; Florell SR; Harris RM; Cannon-Albright LA; Swinyer L; Leachman SA
Arch Dermatol; 2007 Nov; 143(11):1409-12. PubMed ID: 18025365
[TBL] [Abstract][Full Text] [Related]
16. CDKN2A and MC1R analysis in amelanotic and pigmented melanoma.
Ghiorzo P; Pastorino L; Pizzichetta MA; Bono R; Queirolo P; Talamini R; Annessi G; Bruno W; Nasti S; Gargiulo S; Battistuzzi L; Sini MC; Palmieri G; Scarrà GB;
Melanoma Res; 2009 Jun; 19(3):142-5. PubMed ID: 19339902
[TBL] [Abstract][Full Text] [Related]
17. The Y152X MC1R gene mutation: occurrence in ethnically diverse Jewish malignant melanoma patients.
Galore G; Azizi E; Scope A; Pavlotsky F; Yakobson E; Friedman E
Melanoma Res; 2007 Apr; 17(2):105-8. PubMed ID: 17496785
[TBL] [Abstract][Full Text] [Related]
18. MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population.
Fernandez L; Milne R; Bravo J; Lopez J; Avilés J; Longo M; Benítez J; Lázaro P; Ribas G
Carcinogenesis; 2007 Aug; 28(8):1659-64. PubMed ID: 17434924
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor variants and the malignant melanoma risk: a population-based study.
Gapska P; Scott RJ; Serrano-Fernandez P; Mirecka A; Rassoud I; Górski B; Cybulski C; Huzarski T; Byrski T; Nagay L; Maleszka R; Sulikowski M; Lubinski J; Debniak T
Cancer Epidemiol; 2009 Aug; 33(2):103-7. PubMed ID: 19679055
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations of patients with familial or multiple melanoma in Southern Brazil.
Grazziotin TC; Rey MC; Bica CG; Pinto LA; Bonamigo RR; Puig-Butille JA; Cuellar F; Puig S
J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e179-85. PubMed ID: 22621339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
